Merck’s Tough Quarter, Burger King Reports a Whopper, and 3 More Hot Stocks
Merck & Co Inc. (NYSE:MRK): Shares of Merck are trading down, although the firm’s EPS of 52 cents beat by 4 cents. Revenue of $11 billion missed by $0.19 billion as net profit dropped to $1.12 billion from $1.73 billion, dented by acquisitions and restructuring costs. Merck’s Januvia diabetes treatment slipped 5 percent to $927 million as pharmaceutical revenues in total fell 2 percent to $9.475 billion. Animal Health sales also dropped, while unfavorable currency swings put a sizable dent in the international and emerging markets results as well.